Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Severe community-acquired Enterobacter pneumonia: a plea for greater awareness of the concept of health-care-associated pneumonia.

Boyer A, Amadeo B, Vargas F, Yu M, Maurice-Tison S, Dubois V, Bébéar C, Rogues AM, Gruson D.

BMC Infect Dis. 2011 May 11;11:120. doi: 10.1186/1471-2334-11-120.

2.
3.

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS.

Clin Infect Dis. 2013 Nov;57(10):1373-83. doi: 10.1093/cid/cit571. Epub 2013 Sep 2.

PMID:
23999080
4.

[The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia].

Taşbakan MS, Bacakoğlu F, Başoğlu OK, Gürgün A, Başarik B, Citim Tuncel S, Sayiner A.

Tuberk Toraks. 2011;59(4):348-54. Turkish.

5.

Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.

Grenier C, Pépin J, Nault V, Howson J, Fournier X, Poirier MS, Cabana J, Craig C, Beaudoin M, Valiquette L.

J Antimicrob Chemother. 2011 Jul;66(7):1617-24. doi: 10.1093/jac/dkr176. Epub 2011 May 17.

PMID:
21586592
6.

Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.

Falcone M, Venditti M, Shindo Y, Kollef MH.

Int J Infect Dis. 2011 Aug;15(8):e545-50. doi: 10.1016/j.ijid.2011.04.005. Epub 2011 May 26. Review.

7.

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH.

Antimicrob Agents Chemother. 2007 Oct;51(10):3568-73. Epub 2007 Aug 6.

8.

Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.

Lee H, Park JY, Lee T, Lee YJ, Lim HJ, Park JS, Yoon HI, Lee JH, Lee CT, Cho YJ.

Korean J Intern Med. 2016 May;31(3):525-34. doi: 10.3904/kjim.2015.103. Epub 2016 Mar 11.

9.

Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.

Attridge RT, Frei CR, Pugh MJ, Lawson KA, Ryan L, Anzueto A, Metersky ML, Restrepo MI, Mortensen EM.

J Crit Care. 2016 Dec;36:265-271. doi: 10.1016/j.jcrc.2016.08.004. Epub 2016 Aug 11.

10.

The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea.

Jeon EJ, Cho SG, Shin JW, Kim JY, Park IW, Choi BW, Choi JC.

Yonsei Med J. 2011 Mar;52(2):282-7. doi: 10.3349/ymj.2011.52.2.282.

11.

Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.

Gross AE, Van Schooneveld TC, Olsen KM, Rupp ME, Bui TH, Forsung E, Kalil AC.

Antimicrob Agents Chemother. 2014 Sep;58(9):5262-8. doi: 10.1128/AAC.02582-14. Epub 2014 Jun 23.

12.

Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan area of Japan.

Sugisaki M, Enomoto T, Shibuya Y, Matsumoto A, Saitoh H, Shingu A, Narato R, Nomura K.

J Infect Chemother. 2012 Jun;18(3):352-60. doi: 10.1007/s10156-011-0344-9. Epub 2011 Nov 25.

PMID:
22116463
13.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
14.

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.

Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, Hasegawa Y.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):985-95. doi: 10.1164/rccm.201301-0079OC.

PMID:
23855620
15.

Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.

Umeki K, Tokimatsu I, Yasuda C, Iwata A, Yoshioka D, Ishii H, Shirai R, Kishi K, Hiramatsu K, Matsumoto B, Kadota J.

Respirology. 2011 Jul;16(5):856-61. doi: 10.1111/j.1440-1843.2011.01983.x.

PMID:
21545370
16.

The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).

Kaku N, Yanagihara K, Morinaga Y, Izumikawa K, Nagashima S, Kakeya H, Yamamoto Y, Fukuda M, Takatani H, Fukuda M, Hashiguchi K, Kohno S.

J Infect Chemother. 2013 Feb;19(1):70-6. doi: 10.1007/s10156-012-0454-z. Epub 2012 Aug 1.

PMID:
22850821
17.
18.

Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.

Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, Manresa F, Gudiol F.

Arch Intern Med. 2007 Jul 9;167(13):1393-9.

PMID:
17620533
19.

Severe community-acquired pneumonia: an Australian perspective.

Wilson PA, Ferguson J.

Intern Med J. 2005 Dec;35(12):699-705.

PMID:
16313544
20.

Supplemental Content

Support Center